Free Trial

Roche Holding AG (OTCMKTS:RHHBY) Position Trimmed by Saratoga Research & Investment Management

Roche logo with Medical background

Saratoga Research & Investment Management decreased its position in shares of Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 3.5% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 2,325,810 shares of the company's stock after selling 85,311 shares during the quarter. Roche makes up 4.1% of Saratoga Research & Investment Management's investment portfolio, making the stock its 9th largest position. Saratoga Research & Investment Management's holdings in Roche were worth $92,916,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in RHHBY. Lee Danner & Bass Inc. purchased a new stake in Roche in the second quarter worth approximately $327,000. Hantz Financial Services Inc. bought a new stake in shares of Roche during the 2nd quarter valued at about $1,164,000. Waldron Private Wealth LLC purchased a new position in shares of Roche during the 2nd quarter worth approximately $263,000. Rhumbline Advisers grew its stake in Roche by 0.9% in the second quarter. Rhumbline Advisers now owns 103,985 shares of the company's stock worth $3,605,000 after purchasing an additional 904 shares during the period. Finally, Archer Investment Corp grew its holdings in Roche by 10.6% in the second quarter. Archer Investment Corp now owns 6,810 shares of the company's stock worth $236,000 after purchasing an additional 652 shares during the period.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. Bank of America raised shares of Roche from a "neutral" rating to a "buy" rating in a report on Friday, September 13th. Deutsche Bank Aktiengesellschaft downgraded shares of Roche from a "hold" rating to a "sell" rating in a report on Friday, September 13th. Three analysts have rated the stock with a sell rating, one has assigned a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Hold".

Check Out Our Latest Report on Roche

Roche Price Performance

OTCMKTS RHHBY traded up $0.36 on Thursday, hitting $36.00. The stock had a trading volume of 1,505,335 shares, compared to its average volume of 2,015,653. The business's fifty day moving average price is $37.66 and its 200 day moving average price is $37.71. Roche Holding AG has a 52-week low of $29.20 and a 52-week high of $42.43.

Roche Profile

(Free Report)

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.

Read More

Institutional Ownership by Quarter for Roche (OTCMKTS:RHHBY)

Should you invest $1,000 in Roche right now?

Before you consider Roche, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Roche wasn't on the list.

While Roche currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines